Final Overall Survival Analysis of S1500: A Randomized, Phase II Study Comparing Sunitinib With Cabozantinib, Crizotinib, and Savolitinib in Advanced Papillary Renal Cell Carcinoma
S1500研究的最终总生存期分析：一项比较舒尼替尼与卡博替尼、克唑替尼和沙伐替尼治疗晚期乳头状肾细胞癌的随机II期研究
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.24.00767
Barata, Pedro; Tangen, Catherine; Plets, Melissa; Thompson, Ian M Jr; Narayan, Vivek; George, Daniel J; Heng, Daniel Y C; Shuch, Brian; Stein, Mark; Gulati, Shuchi; Tretiakova, Maria; Tripathi, Abhishek; Bjarnason, Georg A; Humphrey, Peter; Adeniran, Adebowale; Vaishampayan, Ulka; Alva, Ajjai; Zhang, Tian; Cole, Scott; Lara, Primo N Jr; Lerner, Seth P; Balzer-Haas, Naomi; Pal, Sumanta K
